Assignee
NEXZOL PHARMA INC
US·4 granted patents·1 pending application·23 citations·filing 2019–2023
Top patents by PatentIndex Score
5 records- 0194US11116730B2Transdermal formulation for the treatment of pain and/or inflammationNEXZOL PHARMA INC·Filed 2020·Granted Sep 14, 2021·9 cites·19 claims
- 0293US10588871B1Transdermal formulation for the treatment of pain and/or inflammationNEXZOL PHARMA INC·Filed 2019·Granted Mar 17, 2020·12 cites·12 claims
- 0391US11723880B2Transdermal formulation for the treatment of pain and/or inflammationNEXZOL PHARMA INC·Filed 2021·Granted Aug 15, 2023·2 cites·20 claims
- 0481US12390480B2Transdermal formulation for the treatment of pain and/or inflammationNEXZOL PHARMA INC·Filed 2023·Granted Aug 19, 2025·0 cites·20 claims
- 0556US2022110860A1Transdermal formulationsNEXZOL PHARMA INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NEXZOL PHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →